2
Announcements
Trials
Browse
Landscape
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
5
Polycythemia Vera
4
Lung Neoplasms
4
Ovarian Neoplasms
3
Myeloproliferative Disorders
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Lymphoma
2
Head and Neck Neoplasms
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Adenocarcinoma
2
Urticaria
1
Tuberous Sclerosis
1
Thymic aplasia
1
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Small Cell Lung Carcinoma
1
Severe Combined Immunodeficiency
1
Sarcoma
1
Salivary Gland Neoplasms
1
Renal Insufficiency, Chronic
1
Rectal Neoplasms
1
Primary Dysautonomias
1
Polycythemia
1
Polycystic Ovary Syndrome
1
Pancreatitis, Chronic
1
Interventions
fludarabine
4
Cyclophosphamide
4
Specimen Handling
2
Nivolumab
2
Natalizumab
2
Interferon beta-1b
2
Fingolimod Hydrochloride
2
Blood Specimen Collection
2
teriflunomide
1
nabiximols
1
gadobutrol
1
gadobenic acid
1
cabozantinib
1
Surveys and Questionnaires
1
Respiratory Therapy
1
Registries
1
Platinum Compounds
1
Platelet Transfusion
1
Plasma Exchange
1
Phlebotomy
1
OM 89
1
Mn-PyC3A
1
Medical Marijuana
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Ipilimumab
1
Interferon beta-1a
1
Injections
1
Gadolinium DTPA
1
Fish Oils
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Multiple Sclerosis
×
Phlebotomy
×
Clear all
NCT04306939
2026-01-07
GREAT1
University of Pittsburgh
Suspended
120,000 enrolled